COP1 N Stock Overview
Provides e-health services worldwide. More details
Snowflake Score | |
---|---|
Valuation | 1/6 |
Future Growth | 3/6 |
Past Performance | 2/6 |
Financial Health | 3/6 |
Dividends | 0/6 |
CompuGroup Medical SE & Co. KGaA Competitors
Price History & Performance
Historical stock prices | |
---|---|
Current Share Price | €1,396.80 |
52 Week High | €0 |
52 Week Low | €0 |
Beta | 1.02 |
11 Month Change | 0% |
3 Month Change | 0% |
1 Year Change | 0% |
33 Year Change | -22.72% |
5 Year Change | n/a |
Change since IPO | -6.39% |
Recent News & Updates
Recent updates
Shareholder Returns
COP1 N | MX Healthcare Services | MX Market | |
---|---|---|---|
7D | 0% | 0% | 0% |
1Y | 0% | 0% | 0% |
Return vs Industry: COP1 N exceeded the MX Healthcare Services industry which returned -10.5% over the past year.
Return vs Market: COP1 N underperformed the MX Market which returned 3.7% over the past year.
Price Volatility
COP1 N volatility | |
---|---|
COP1 N Average Weekly Movement | n/a |
Healthcare Services Industry Average Movement | 0% |
Market Average Movement | 0% |
10% most volatile stocks in MX Market | 0% |
10% least volatile stocks in MX Market | 0% |
Stable Share Price: COP1 N has not had significant price volatility in the past 3 months.
Volatility Over Time: Insufficient data to determine COP1 N's volatility change over the past year.
About the Company
Founded | Employees | CEO | Website |
---|---|---|---|
1987 | 8,825 | Michael Rauch | www.cgm.com |
CompuGroup Medical SE & Co. KGaA develops and sells software and information technology solutions for the healthcare sector worldwide. The company’s Ambulatory Information Systems segment develop and sell practice management software for registered physicians, medical care centers, and physician networks; and offers supplementary internet and intranet solutions. Its Pharmacy Information Systems segment develop and sell administrative and billing related software applications, which includes procuring and shipping, managing and controlling inventory, planning, performing, and monitoring retail activities for pharmacies.
CompuGroup Medical SE & Co. KGaA Fundamentals Summary
COP1 N fundamental statistics | |
---|---|
Market cap | Mex$45.00b |
Earnings (TTM) | Mex$1.29b |
Revenue (TTM) | Mex$22.56b |
34.8x
P/E Ratio2.0x
P/S RatioIs COP1 N overvalued?
See Fair Value and valuation analysisEarnings & Revenue
COP1 N income statement (TTM) | |
---|---|
Revenue | €1.21b |
Cost of Revenue | €780.33m |
Gross Profit | €433.37m |
Other Expenses | €363.79m |
Earnings | €69.58m |
Last Reported Earnings
Mar 31, 2023
Next Earnings Date
Aug 10, 2023
Earnings per share (EPS) | 1.33 |
Gross Margin | 35.71% |
Net Profit Margin | 5.73% |
Debt/Equity Ratio | 96.4% |
How did COP1 N perform over the long term?
See historical performance and comparison